Portal de Periódicos da CAPES

Artigo Produção Nacional Revisado por pares

BIBTEX RIS

Plasma levels of alarmin IL-33 are unchanged in autism spectrum disorder: A preliminary study

2014; Elsevier BV; Volume: 278; Linguagem: Inglês

10.1016/j.jneuroim.2014.11.021

1872-8421

Izabela Guimarães Barbosa, David Henrique Rodrigues, Natália Pessoa Rocha, Larissa Fonseca da Cunha Sousa, Érica Leandro Marciano Vieira, Ana Cristina Simões e Silva, Arthur Kümmer, Antônio Lúcio Teixeira,

Eosinophilic Esophagitis

The pathogenesis of autism spectrum disorder (ASD) is unknown, and the immune system has been appointed to play an important role. The interleukin 33 (IL-33), a member of the IL-1, may act as an alarmin. This study aimed to evaluate plasma levels of IL-33, sST2, and IL-1β in 30 patients with ASD in comparison with 18 controls matched by gender, age and maternal age at childbirth. Patients did not differ from controls in IL-33, sST2, and IL-1β plasma levels. Alarmin levels were not correlated with age, and neither was influenced by clinical parameters. Our results undermine the role of IL-33/ST2 in ASD.